The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Daptomycin-Global Market Insights and Sales Trends 2025
Synopsis
Daptomycin is a lipopeptide antibiotic used in the treatment of systemic and life-threatening infections caused by Gram-positive organisms.
The global Daptomycin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Daptomycin in various end use industries. The expanding demands from the Adult and Pediatric Patients (1 to 17 years of age), are propelling Daptomycin market. 350 mg Lyophilized Powder, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 500 mg Lyophilized Powder segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Daptomycin market, driven by demand from China, the second largest economy with some signs of stabilising, the Daptomycin market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Daptomycin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Daptomycin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Daptomycin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Daptomycin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Daptomycin covered in this report include Merck & Co., Pfizer, Teva, Mylan, Fresenius Kabi, Sagent Pharmaceuticals, Xellia, Hisun and HENGRUI PHARMA, etc.
The global Daptomycin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co.
Pfizer
Teva
Mylan
Fresenius Kabi
Sagent Pharmaceuticals
Xellia
Hisun
HENGRUI PHARMA
Huadong Medicine
Global Daptomycin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Daptomycin market, Segment by Type:
350 mg Lyophilized Powder
500 mg Lyophilized Powder
Global Daptomycin market, by Application
Adult
Pediatric Patients (1 to 17 years of age)
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Daptomycin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Daptomycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Daptomycin is a lipopeptide antibiotic used in the treatment of systemic and life-threatening infections caused by Gram-positive organisms.
The global Daptomycin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Daptomycin in various end use industries. The expanding demands from the Adult and Pediatric Patients (1 to 17 years of age), are propelling Daptomycin market. 350 mg Lyophilized Powder, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 500 mg Lyophilized Powder segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Daptomycin market, driven by demand from China, the second largest economy with some signs of stabilising, the Daptomycin market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Daptomycin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Daptomycin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Daptomycin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Daptomycin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Daptomycin covered in this report include Merck & Co., Pfizer, Teva, Mylan, Fresenius Kabi, Sagent Pharmaceuticals, Xellia, Hisun and HENGRUI PHARMA, etc.
The global Daptomycin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co.
Pfizer
Teva
Mylan
Fresenius Kabi
Sagent Pharmaceuticals
Xellia
Hisun
HENGRUI PHARMA
Huadong Medicine
Global Daptomycin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Daptomycin market, Segment by Type:
350 mg Lyophilized Powder
500 mg Lyophilized Powder
Global Daptomycin market, by Application
Adult
Pediatric Patients (1 to 17 years of age)
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Daptomycin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Daptomycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Daptomycin Market Overview
1.1 Daptomycin Product Overview
1.2 Daptomycin Market Segment by Type
1.2.1 350 mg Lyophilized Powder
1.2.2 500 mg Lyophilized Powder
1.3 Global Daptomycin Market Size by Type
1.3.1 Global Daptomycin Market Size Overview by Type (2018-2029)
1.3.2 Global Daptomycin Historic Market Size Review by Type (2018-2023)
1.3.3 Global Daptomycin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Daptomycin Sales Breakdown by Type (2018-2023)
1.4.2 Europe Daptomycin Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Daptomycin Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Daptomycin Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Daptomycin Sales Breakdown by Type (2018-2023)
2 Global Daptomycin Market Competition by Company
2.1 Global Top Players by Daptomycin Sales (2018-2023)
2.2 Global Top Players by Daptomycin Revenue (2018-2023)
2.3 Global Top Players by Daptomycin Price (2018-2023)
2.4 Global Top Manufacturers Daptomycin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Daptomycin Market Competitive Situation and Trends
2.5.1 Daptomycin Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Daptomycin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Daptomycin as of 2022)
2.7 Date of Key Manufacturers Enter into Daptomycin Market
2.8 Key Manufacturers Daptomycin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Daptomycin Status and Outlook by Region
3.1 Global Daptomycin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Daptomycin Historic Market Size by Region
3.2.1 Global Daptomycin Sales in Volume by Region (2018-2023)
3.2.2 Global Daptomycin Sales in Value by Region (2018-2023)
3.2.3 Global Daptomycin Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Daptomycin Forecasted Market Size by Region
3.3.1 Global Daptomycin Sales in Volume by Region (2024-2029)
3.3.2 Global Daptomycin Sales in Value by Region (2024-2029)
3.3.3 Global Daptomycin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Daptomycin by Application
4.1 Daptomycin Market Segment by Application
4.1.1 Adult
4.1.2 Pediatric Patients (1 to 17 years of age)
4.2 Global Daptomycin Market Size by Application
4.2.1 Global Daptomycin Market Size Overview by Application (2018-2029)
4.2.2 Global Daptomycin Historic Market Size Review by Application (2018-2023)
4.2.3 Global Daptomycin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Daptomycin Sales Breakdown by Application (2018-2023)
4.3.2 Europe Daptomycin Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Daptomycin Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Daptomycin Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Daptomycin Sales Breakdown by Application (2018-2023)
5 North America Daptomycin by Country
5.1 North America Daptomycin Historic Market Size by Country
5.1.1 North America Daptomycin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Daptomycin Sales in Volume by Country (2018-2023)
5.1.3 North America Daptomycin Sales in Value by Country (2018-2023)
5.2 North America Daptomycin Forecasted Market Size by Country
5.2.1 North America Daptomycin Sales in Volume by Country (2024-2029)
5.2.2 North America Daptomycin Sales in Value by Country (2024-2029)
6 Europe Daptomycin by Country
6.1 Europe Daptomycin Historic Market Size by Country
6.1.1 Europe Daptomycin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Daptomycin Sales in Volume by Country (2018-2023)
6.1.3 Europe Daptomycin Sales in Value by Country (2018-2023)
6.2 Europe Daptomycin Forecasted Market Size by Country
6.2.1 Europe Daptomycin Sales in Volume by Country (2024-2029)
6.2.2 Europe Daptomycin Sales in Value by Country (2024-2029)
7 Asia-Pacific Daptomycin by Region
7.1 Asia-Pacific Daptomycin Historic Market Size by Region
7.1.1 Asia-Pacific Daptomycin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Daptomycin Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Daptomycin Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Daptomycin Forecasted Market Size by Region
7.2.1 Asia-Pacific Daptomycin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Daptomycin Sales in Value by Region (2024-2029)
8 Latin America Daptomycin by Country
8.1 Latin America Daptomycin Historic Market Size by Country
8.1.1 Latin America Daptomycin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Daptomycin Sales in Volume by Country (2018-2023)
8.1.3 Latin America Daptomycin Sales in Value by Country (2018-2023)
8.2 Latin America Daptomycin Forecasted Market Size by Country
8.2.1 Latin America Daptomycin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Daptomycin Sales in Value by Country (2024-2029)
9 Middle East and Africa Daptomycin by Country
9.1 Middle East and Africa Daptomycin Historic Market Size by Country
9.1.1 Middle East and Africa Daptomycin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Daptomycin Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Daptomycin Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Daptomycin Forecasted Market Size by Country
9.2.1 Middle East and Africa Daptomycin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Daptomycin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck & Co.
10.1.1 Merck & Co. Company Information
10.1.2 Merck & Co. Introduction and Business Overview
10.1.3 Merck & Co. Daptomycin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck & Co. Daptomycin Products Offered
10.1.5 Merck & Co. Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Daptomycin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer Daptomycin Products Offered
10.2.5 Pfizer Recent Development
10.3 Teva
10.3.1 Teva Company Information
10.3.2 Teva Introduction and Business Overview
10.3.3 Teva Daptomycin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Teva Daptomycin Products Offered
10.3.5 Teva Recent Development
10.4 Mylan
10.4.1 Mylan Company Information
10.4.2 Mylan Introduction and Business Overview
10.4.3 Mylan Daptomycin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Mylan Daptomycin Products Offered
10.4.5 Mylan Recent Development
10.5 Fresenius Kabi
10.5.1 Fresenius Kabi Company Information
10.5.2 Fresenius Kabi Introduction and Business Overview
10.5.3 Fresenius Kabi Daptomycin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Fresenius Kabi Daptomycin Products Offered
10.5.5 Fresenius Kabi Recent Development
10.6 Sagent Pharmaceuticals
10.6.1 Sagent Pharmaceuticals Company Information
10.6.2 Sagent Pharmaceuticals Introduction and Business Overview
10.6.3 Sagent Pharmaceuticals Daptomycin Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sagent Pharmaceuticals Daptomycin Products Offered
10.6.5 Sagent Pharmaceuticals Recent Development
10.7 Xellia
10.7.1 Xellia Company Information
10.7.2 Xellia Introduction and Business Overview
10.7.3 Xellia Daptomycin Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Xellia Daptomycin Products Offered
10.7.5 Xellia Recent Development
10.8 Hisun
10.8.1 Hisun Company Information
10.8.2 Hisun Introduction and Business Overview
10.8.3 Hisun Daptomycin Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Hisun Daptomycin Products Offered
10.8.5 Hisun Recent Development
10.9 HENGRUI PHARMA
10.9.1 HENGRUI PHARMA Company Information
10.9.2 HENGRUI PHARMA Introduction and Business Overview
10.9.3 HENGRUI PHARMA Daptomycin Sales, Revenue and Gross Margin (2018-2023)
10.9.4 HENGRUI PHARMA Daptomycin Products Offered
10.9.5 HENGRUI PHARMA Recent Development
10.10 Huadong Medicine
10.10.1 Huadong Medicine Company Information
10.10.2 Huadong Medicine Introduction and Business Overview
10.10.3 Huadong Medicine Daptomycin Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Huadong Medicine Daptomycin Products Offered
10.10.5 Huadong Medicine Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Daptomycin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Daptomycin Industrial Chain Analysis
11.4 Daptomycin Market Dynamics
11.4.1 Daptomycin Industry Trends
11.4.2 Daptomycin Market Drivers
11.4.3 Daptomycin Market Challenges
11.4.4 Daptomycin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Daptomycin Distributors
12.3 Daptomycin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
